Explore all the different treatment options for IBS-D, including Xifaxan’s unique mechanism of action surrounding the microbiome. In addition, learn about behavioral considerations, such as anxiety and depression, that can accompany IBS-D and contribute to worsening symptoms, fecal incontinence issues, and the role of dietary therapies.

Featuring an expert panel of speakers, Baha Moshiree, MD, Elyse Thakur, PhD and Kate Scarlata, MPH, RDN

Special thank you to Salix Pharmaceuticals for their support of this educational program.